Enlivex Therapeutics Ltd. Ordinary Shares (ENLV) stock analysis and AI prediction
The company facts of Enlivex Therapeutics Ltd. Ordinary Shares, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Enlivex Therapeutics Ltd. Ordinary Shares
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
- Exchange
- NASDAQ
- Market value
- $1.9 million
- Size
- Micro cap
- Employees
- 34
- Listed since
- July 31, 2014
- Website
- enlivex.com
ENLV questions
What is the AI prediction for ENLV stock?
Each market day our model rates Enlivex Therapeutics Ltd. Ordinary Shares (ENLV) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the ENLV prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for ENLV?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see ENLV options?
The ENLV options page opens its calls and puts, with price, volume, implied volatility and the Greeks.